Loading video...

Video Failed to Load

Go Home

Open, community-funded science is already producing real outcomes. Eli Lilly just bought Crossbridge Bio for $300M. The company grew out of one of the ecosystem's earliest community-funded research grants. Years in the making. Across the ecosystem so far: $2B+ in research IP traded, $50M+ into real science.

16,834 views • 2 months ago •via X (Twitter)

7 Comments

ramazan's profile picture
ramazan2 months ago

@erhanunal Sonuç yok reis asagi şort

Civic NodeX | Crypto Scout's profile picture
Civic NodeX | Crypto Scout2 months ago

Bio could become the low-cost operating system for agentic science. But the transition from a highly promising project to a high-conviction gem requires passing three tests: PeptAI must publish quantitative, replicable experimental results. BIOS must demonstrate prospectively that its ranking improves wet-lab hit rates. Bio must clarify how revenue, data, IP, and equity generate measurable value for BIO and veBIO.

lee's profile picture
lee2 months ago

하 또 사기치네

Michael J Altman's profile picture
Michael J Altman2 months ago

💡 $BIO at a glance Emma AI has more details @BlockIndexAI 🔥 Sign up free at

𝑪𝑹𝒀𝑷𝑻Ø𝑳Ø𝑹𝑫𝒁's profile picture
𝑪𝑹𝒀𝑷𝑻Ø𝑳Ø𝑹𝑫𝒁2 months ago

Congrats on this milestone for decentralized science Crossbridge Bio's $300M acquisition by Eli Lilly shows community-funded research via VitaDAO can deliver real commercial outcomes after years of development.

grlclskn's profile picture
grlclskn2 months ago

Yahu yeter artık.neden alsınlar. Aldırıp durma. Seni bile kandırıyorlar. Bu kadar kişinin vebali çok ağır Erhan kardeşim sana. Uyuyamazsin

Еlena's profile picture
Еlena2 months ago

let’s revive desci again team!

Related Videos